Govt Proposes Quick Suspension of Substandard Drug Licences
The Centre has proposed a change to drug rules that would let authorities suspend manufacturing licences of substandard medicines straight away. Under the proposed amendment, makers must first take mandatory corrective steps before a licence can be revoked. The suspension stays in place until the manufacturer carries out that corrective action.
Context
Context: India has faced several cases of contaminated or substandard medicines in recent years, which led to calls for tighter checks on drug makers. The proposal would change how the licensing regulator responds to such failures.